Autocrine IL-3, mechanisms contribute to the transforming activity of BCR-ABL-transduced murine hematopoietic cells in vitro and in vivo.

被引：0
|
作者：
Jiang, XY
Ng, E
Chalandon, Y
Stuible, M
Eisterer, W
Eaves, A
Eaves, C
机构：
[1] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[2] Universitaklin Innere Med, Innsbruck, Austria
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3480
引用
收藏
页码：837A / 837A
页数：1
相关论文
共 12 条
  • [1] Reduced tyrosine phosphorylation of P210BCR-ABL and lack of STAT5 activation in BCR-ABL-transduced IL-3-/- primitive hematopoietic cells.
    Jiang, XY
    Yip, C
    Eisterer, W
    Eaves, A
    Eaves, C
    BLOOD, 2000, 96 (11) : 92A - 92A
  • [2] Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo
    Jiang, XY
    Ng, E
    Yip, C
    Eisterer, W
    Chalandon, Y
    Stuible, M
    Eaves, A
    Eaves, CJ
    BLOOD, 2002, 100 (10) : 3731 - 3740
  • [3] The biological role of the IL-3 receptor agonist in myelopoietin-mediated tyrosine phosphorylation and proliferation in vitro and hematopoietic recovery in vivo.
    Li, XO
    Hood, WF
    Klein, BK
    Polazzi, JO
    Welply, JK
    Smith, WG
    Shieh, JJJ
    Abegg, AL
    Farese, AM
    Casey, DB
    Vigneulle, RM
    MacVittie, TJ
    McKearn, JP
    Monahan, JB
    BLOOD, 1999, 94 (10) : 472A - 472A
  • [4] Deregulated expression of a novel oncogene,ahi-1, in murine hematopoietic cells confers a proliferative advantage in vitro and leukemogenic activity in vivo and enhances the effects of BCR-ABL.
    Zhou, Leon
    Ringrose, Ashley
    Lin, Ann E. -J.
    Jiang, Xiaoyan
    BLOOD, 2006, 108 (11) : 119A - 119A
  • [5] A novel tool for the detection of phosphatidylinositol-(3,4,5)-trisphosphate in primitive hematopoietic stem cells: Characterization of the response to IL-3 and Bcr-Abl.
    Xenaki, D
    Gray, A
    Downes, CP
    Owen-Lynch, PJ
    BLOOD, 2001, 98 (11) : 290A - 291A
  • [6] Effects of constitutive mutants of the GM-CSF/IL-3/IL-5 receptor β subunit on proliferation and differentiation of haemopoietic cells in vitro and in vivo.
    Gonda, TJ
    McCormack, MP
    Blake, TJ
    D'Andrea, RJ
    BLOOD, 1999, 94 (10) : 148B - 148B
  • [7] Bcr-Abl kinase activity is necessary for IL-3 independent cell proliferation, but not for inhibition of G-CSF induced myeloid differentiation in the murine myeloid progenitor cell line 32D.
    Danhauser-Riedl, S
    Schuster, C
    Warmuth, M
    Stanglmaier, M
    Emmerich, B
    Hallek, M
    BLOOD, 1998, 92 (10) : 94A - 94A
  • [8] An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells
    Guinn, BA
    Evely, RS
    Walsh, V
    Gilkes, AF
    Burnett, AK
    Mills, KI
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 393 - 404
  • [9] PARTIALLY PURIFIED EXTRACT OF URINE FROM PATIENTS WITH APLASTIC-ANEMIA HAS INTERLEUKIN-3 (IL-3) OR BURST PROMOTING ACTIVITY (BPA) TO MURINE HEMATOPOIETIC PROGENITOR CELLS-INVITRO AND INVIVO
    ABE, T
    SUGIMOTO, M
    FUHRER, JP
    BREGMAN, MD
    KURAMOTO, A
    MURPHY, MJ
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 529 - 529
  • [10] TRANSFORMING GROWTH-FACTOR-BETA REGULATES THE CELL-CYCLE STATUS OF INTERLEUKIN-3 (IL-3) PLUS IL-1, STEM-CELL FACTOR, OR IL-6 STIMULATED CD34+ HUMAN HEMATOPOIETIC PROGENITOR CELLS THROUGH DIFFERENT CELL KINETIC MECHANISMS DEPENDING ON THE APPLIED STIMULUS
    LARDON, F
    SNOECK, HW
    NIJS, G
    LENJOU, M
    PEETERMANS, ME
    RODRIGUS, I
    BERNEMAN, ZN
    VANBOCKSTAELE, DR
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (09) : 903 - 909
12